BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28691132)

  • 21. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
    Galantino ML; Desai K; Greene L; Demichele A; Stricker CT; Mao JJ
    Integr Cancer Ther; 2012 Dec; 11(4):313-20. PubMed ID: 21733988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
    Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
    J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias.
    Schnell PM; Lustberg MB; Henry NL
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33842832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
    Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
    Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.
    Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS
    Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nordic Walking as an Exercise Intervention to Reduce Pain in Women With Aromatase Inhibitor-Associated Arthralgia: A Feasibility Study.
    Fields J; Richardson A; Hopkinson J; Fenlon D
    J Pain Symptom Manage; 2016 Oct; 52(4):548-559. PubMed ID: 27265816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
    Crew KD; Capodice JL; Greenlee H; Apollo A; Jacobson JS; Raptis G; Blozie K; Sierra A; Hershman DL
    J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors.
    Mao JJ; Bruner DW; Stricker C; Farrar JT; Xie SX; Bowman MA; Pucci D; Han X; DeMichele A
    Integr Cancer Ther; 2009 Jun; 8(2):123-9. PubMed ID: 19679620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
    Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
    Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.
    Campbell A; Heydarian R; Ochoa C; Dwivedi AK; Nahleh ZA
    Breast J; 2018 May; 24(3):260-268. PubMed ID: 29442401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
    Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
    J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
    Chen L; Lin CC; Huang TW; Kuan YC; Huang YH; Chen HC; Kao CY; Su CM; Tam KW
    Breast; 2017 Jun; 33():132-138. PubMed ID: 28384564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study.
    Garcia-Giralt N; Rodríguez-Sanz M; Prieto-Alhambra D; Servitja S; Torres-Del Pliego E; Balcells S; Albanell J; Grinberg D; Diez-Perez A; Tusquets I; Nogués X
    Breast Cancer Res Treat; 2013 Jul; 140(2):385-95. PubMed ID: 23868189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Krop IE; Mayer IA; Ganju V; Dickler M; Johnston S; Morales S; Yardley DA; Melichar B; Forero-Torres A; Lee SC; de Boer R; Petrakova K; Vallentin S; Perez EA; Piccart M; Ellis M; Winer E; Gendreau S; Derynck M; Lackner M; Levy G; Qiu J; He J; Schmid P
    Lancet Oncol; 2016 Jun; 17(6):811-821. PubMed ID: 27155741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
    Moscetti L; Agnese Fabbri M; Sperduti I; Fabrizio N; Frittelli P; Massari A; Pompei L; D'Auria G; Pofi E; Ruggeri EM
    Tumori; 2015; 101(5):469-73. PubMed ID: 26108239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of concurrent prescription antiarthralgia pharmacotherapy on persistence to aromatase inhibitors in treatment-naive postmenopausal females.
    Hashem MG; Cleary K; Fishman D; Nichols L; Khalid M
    Ann Pharmacother; 2013 Jan; 47(1):29-34. PubMed ID: 23324501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
    Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL
    Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
    Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
    Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Hong D; Bi L; Zhou J; Tong Y; Zhao Q; Chen J; Lu X
    Oncotarget; 2017 Jun; 8(25):40558-40567. PubMed ID: 28489562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.